Over half a million Canadians are currently living with Alzheimer's disease or a related form of dementia, and with a rapidly aging population, that number is projected to double by 2031.
Now more than ever, research is necessary to advance programs that help individuals and families dealing with dementia. The Canadian Alzheimer's disease biomarker testing program, developed by Dr. Mari DeMarco, a Clinical Chemist at St. Paul's Hospital, can help doctors accurately diagnose the disease even when only mild symptoms are present.
Dr. DeMarco is one of many neuroscientists around the world working to find new solutions to dementia testing and management. Brain Canada supports leading clinicians and scientists in Canada every year to achieve better outcomes for people living with dementia and Alzheimer's disease.
This research helps aid in preparation and management of this life-altering disease that affects so many. But we need Canadians like you to support this work.
Sign now to support new research and testing for people living with dementia!
